ClinicalTrials.gov
public full text
Public Domain
PREVENtion of HeartMate II Pump Thrombosis
The purpose of this study is to assess how often blood clots form in the FDA-approved HeartMate® II (HM II) Left Ventricular Assist Device (LVAD) and to identify risks related to clotting within the pump.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pressure Volume Loop#848185
- Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)#1197779
- Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY#914228
- Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study#812688
- Safety and Efficacy Study of Fitaya Vena Cava Filter#992648
Record · ID 1418564
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive